NCT00496509View on ClinicalTrials.gov

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

ZD6474 (Zactima) 100mg

PROCEDURE

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MR)

PROCEDURE

Biomarker Draws

DRUG

ZD6474 (Zactima) 300mg

Trial Locations (1)

Unknown

Research Site, Freiberg

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00496509 - Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter